CCP opens second phase review on the proposed acquisition of vaccines business (excluding influenza vaccines business except in china) of Novartis ag by Glaxosmithkline plc.* Islamabad,
The Competition Commission of Pakistan opens an in-depth investigation on a merger in the pharmaceutical sector regarding the market of meningococcal vaccines (Novartis / GSK)
Access to this article is restricted to subscribers
Already Subscribed? Sign-in
Access to this article is restricted to subscribers.
Read one article for free
Sign-up to read this article for free and discover our services.